Skip to main content
227 results:
11. The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure  
The diagnostic company SphingoTec GmbH announces new evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery…  
12. SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India  
SphingoTec and Rivaara Labs today announced that they have entered into a multi-year distribution agreement for the commercialization of SphingoTec’s point of care diagnostic solutions in the Indian…  
13. Proenkephalin (penKid) sheds light on the diagnostic blind spots in assessing acute kidney injury in children  
SphingoTec announces that its kidney function biomarker penKid is reliably identifying AKI in infants, offering a solution to the shortcomings in pediatric critical care. AKI is mostly diagnosed too…  
14. www.sphingotec.com  
Follow our Journey on Social Media View all Events View all News Events & Expos Latest News Subscribe to our Newsletter Follow the link below to subscribe to our…  
Search results 11 until 20 of 227